FDA’s Approval of Pharmacists Prescribing Paxlovid
By: Imaan Sekhery, PharmD Candidate c/o 2025 On July 6, 2022, the Food and Drug Administration (FDA) revised the…
FDA Approves Tubeless Automated Insulin System for Kids 2 Years of Age and Older
By: Geraldine Ciaccio, PharmD Candidate c/o 2025 Young children with type 1 diabetes (T1D) are completely dependent on others…
New FDA Approval of Bydureon for Treating Type 2 Diabetes in Pediatric Patients
By: Kelly Lavery, PharmD Candidate c/o 2024 Increasing rates of childhood obesity remain a major risk factor behind a…
Rho Chi Talks: The Reality of an Emergency Medicine Pharmacist
Featuring: Colleen Bond, PharmD, BCPSBy: Justin Budz, PharmD Candidate c/o 2023 At a young age, Dr. Colleen Bond was involved…
Mounjaro (Tirzepatide): Dual-Targeted Treatment for Type 2 Diabetes
By: Zarin Chowdhury, PharmD Candidate c/o 2023 and Lauren Merkovich, PharmD Candidate c/o 2023 Type 2 diabetes (T2D) is…
Wegovy® (Semaglutide): New FDA Approval for Use in Obesity
By: Pauline Choi, PharmD There has been an increase in the prevalence of obesity, and it has become an…
6th Year Perspective: Experiences in the Pharmaceutical Industry
Featuring: Khushbu Doshi, PharmD Candidate c/o 2023By: Justin Budz, PharmD Candidate c/o 2023 Khushbu Doshi is a sixth-year pharmacy student…
Standing Order for Naloxone in Pharmacies in New York State: A Step Closer in Pharmacy Advocacy
By: Helen Li, PharmD Candidate c/o 2023 On August 15, 2022, the New York State Commissioner of Health, Dr.…
Balancing Early and Appropriate Antibiotic Therapy and Antimicrobial Stewardship Efforts in Sepsis and Septic Shock
By: Angela Basir, PharmD Candidate c/o 2023 and Muatasem Jaser, PharmD Candidate c/o 2023 Sepsis is a clinical syndrome…
Paxlovid, the First Oral Antiviral Treatment for Covid-19
By: Kirby An, PharmD Candidate c/o 2023 Coronavirus Disease (Covid-19) is a virus that took the world by storm…